MedTrace Logo

Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS)

NCT02388139 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2016-01-13

No results posted yet for this study

Summary

Aims

* assessment of renal artery stenosis incidence in consecutive AMI patients included in the Romanian National Programme of Primary Percutaneous Revascularisation;
* generating a cardio-renal-metabolic profile in patients with renal atherosclerotic disease;
* creating a local registry (based on European CARDS percutaneous interventional registries) which also includes renal, metabolic and vascular data;
* reporting long-term follow-up data on major cardiac adverse events (MACE) in the study group.

Conditions

Interventions

PROCEDURE

renal artery angiography

preprocedural renal arteriogram is obtained after sterile preparation and draping of the patient, conscious sedation, infiltration of local anesthetic (lidocaine solution) at the femoral access site, placement of an arterial sheath in the femoral artery, and advancement of the renal guide catheter over a 0.035-in guidewire under fluoroscopic guidance. After the tip of the guide catheter is positioned at the ostium of the renal artery, an angiogram is obtained. After the guidewire is removed, the proximal end of the catheter is connected to a manifold, and 4-8 mL of contrast is manually injected during cineangiographic recording. An intravenous antithrombotic agent, usually heparin, is administered before the clinician proceeds with angioplasty.

PROCEDURE

coronarography

PROCEDURE

coronary angioplasty

PROCEDURE

pulse wave velocity measurement

is a measure of arterial stiffness with Sphigmocore device.

PROCEDURE

body composition monitoring

using Fresenius device

Sponsors & Collaborators

  • Grigore T. Popa University of Medicine and Pharmacy

    lead OTHER

Principal Investigators

  • Alexandru Burlacu, MD · University of Medicine and Pharmacy "Gr T Popa" Iasi

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-10-31
Completion
2017-06-30

Countries

  • Romania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02388139 on ClinicalTrials.gov